323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA
Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel
ALX Oncology Secures $10M Loan Agreement with HSBC Ventures
Annual Meeting Results: Election of Directors and Executive Compensation Vote
Reports First Quarter 2026 Financial Results and Provides Corporate Update
Annual Report to Security Holders
Appoints Jeff Knight as Chief Development and Operating Officer
Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Q2
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
SC TO-I
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Amended Schedule 13G - Ownership Report
Correspondence
Submission Upload
Amended Tender Offer Statement by Issuer